These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
575 related items for PubMed ID: 14717908
1. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Abate N, Chandalia M, Cabo-Chan AV, Moe OW, Sakhaee K. Kidney Int; 2004 Feb; 65(2):386-92. PubMed ID: 14717908 [Abstract] [Full Text] [Related]
3. Insulin resistance and low urinary citrate excretion in calcium stone formers. Cupisti A, Meola M, D'Alessandro C, Bernabini G, Pasquali E, Carpi A, Barsotti G. Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967 [Abstract] [Full Text] [Related]
4. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers. Negri AL, Spivacow R, Del Valle E, Pinduli I, Marino A, Fradinger E, Zanchetta JR. Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420 [Abstract] [Full Text] [Related]
5. Increased production and reduced urinary buffering of acid in uric acid stone formers is ameliorated by pioglitazone. Maalouf NM, Poindexter JR, Adams-Huet B, Moe OW, Sakhaee K. Kidney Int; 2019 May; 95(5):1262-1268. PubMed ID: 30795852 [Abstract] [Full Text] [Related]
11. Idiopathic recurrent calcium urolithiasis (IRCU): an acid meal challenge uncovers inappropriate pH of postprandial, fasting and daily urine: a cross-sectional study of male patients providing insight into post- and pre-load urinary stone substances, crystallization risk, presence of stones, renal transport and systemic metabolic factors. Schwille PO, Wipplinger J. Eur J Med Res; 2008 Jul 28; 13(7):332-42. PubMed ID: 18700191 [Abstract] [Full Text] [Related]
12. Assessment of Urinary Inhibitor or Promoter Activity in Uric Acid Nephrolithiasis. Doizi S, Rodgers K, Poindexter J, Sakhaee K, Maalouf NM. J Urol; 2016 Jun 28; 195(6):1799-804. PubMed ID: 26723865 [Abstract] [Full Text] [Related]
13. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi]. Hess B. Ther Umsch; 2003 Feb 28; 60(2):79-87. PubMed ID: 12649986 [Abstract] [Full Text] [Related]
14. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. Cameron MA, Maalouf NM, Adams-Huet B, Moe OW, Sakhaee K. J Am Soc Nephrol; 2006 May 28; 17(5):1422-8. PubMed ID: 16597681 [Abstract] [Full Text] [Related]
16. Uric acid stone disease: lessons from recent human physiologic studies. Tran TVM, Maalouf NM. Curr Opin Nephrol Hypertens; 2020 Jul 28; 29(4):407-413. PubMed ID: 32398609 [Abstract] [Full Text] [Related]
17. Association of urinary pH with body weight in nephrolithiasis. Maalouf NM, Sakhaee K, Parks JH, Coe FL, Adams-Huet B, Pak CY. Kidney Int; 2004 Apr 28; 65(4):1422-5. PubMed ID: 15086484 [Abstract] [Full Text] [Related]